Drug Trial Radar · NCT02496754
Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization
Last checked: Nov 19, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,266
Actual
Start
Jun 2016
Primary completion
Dec 2022
Study completion Dec 2024
Sponsor
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 14, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 22 years, up to 38 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Pituitary down regulation is widely used during in vitro fertilization (IVF) procedures. It can suppress the spontaneous luteinizing hormone (LH) surge, and can also make follicles growth evenly. At present, standard gonadotropin releasing hormone analogue (GnRH-a) long protocol is used in arou Long term GnRH-a, which is usually used in patients with endometriosis,has been shown to increase IVF outcome by altering endometrial receptivity. Moreover, it is also very convenient because patients do not have to inject GnRH-a daily. In order to make patients feel more comfortable during IVF treatment, the investigators have used a new ovarian stimulation protocol since the beginning of 2015. The investigators give patients long term GnRH-a (3.75mg) once at menstrual cycle D2, and begin the use of Gn to stimulate follicle growth around 30 days later based on the hormone levels and follicle size. In the pilot observational study of several patients, no LH surge occurred during ovarian stimulation. The aim of this randomized controlled study is to compare the efficiency of this new protocol and standard GnRH-a long protocol in the investigator's center.
Conditions
- Clinical Pregnancy Rate
- Ovulation Induction
- IVF
Interventions
GnRH-aDrug
In experimental group, patients use long term GnRH-a; Patients' serum or follicle fluid will be collected if needed.
GnRH-antaDrug
In control group, patients use GnRH-antagonist. Patients' serum or follicle fluid will be collected if needed.
Primary outcomes
What the sponsor says the trial is designed to measure.
- clinical pregnancy rateTime frame: 5 weeks after embryo transfer
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Reproductive Medical Center, 1st Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.